Bluefin Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,300
Closed -$2.46K 139
2024
Q2
$2.46K Buy
27,300
+6,900
+34% +$1.03M ﹤0.01% 107
2024
Q1
$1.84K Buy
20,400
+10,400
+104% +$1.66M ﹤0.01% 133
2023
Q4
$200 Buy
+10,000
New +$1.53M ﹤0.01% 248
2019
Q4
Sell
-19,100
Closed -$22K 672
2019
Q3
$22K Buy
+19,100
New +$2.52M ﹤0.01% 429
2018
Q3
Sell
-16,000
Closed -$1K 537
2018
Q2
$1K Buy
+16,000
New +$2M ﹤0.01% 412
2014
Q3
Sell
-376
Closed -$300K 1012
2014
Q2
$300K Buy
+376
New +$38K 0.01% 530

Other funds holding JNJ

Bluefin Capital Management's JNJ Position: Q4 2022 in Review

Bluefin Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 2,570 shares — an estimated $420K sold.

Bluefin Capital Management first reported a position in JNJ in Q2 2013 and held it in 33 quarters. The position peaked at $14.8M in Q4 2019. 3,789 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Bluefin Capital Management reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 2,570 Johnson & Johnson shares in Q4 2022, an estimated $420K.
  • Bluefin Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 33 quarters.
  • Bluefin Capital Management's Johnson & Johnson position peaked at $14.8M in Q4 2019.
  • 3,789 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Bluefin Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.